Mosaic Reports Significant Q1 Loss, $442M in Charges, and Production Curtailments Amid High Input Costs

summarizeSummary

Mosaic reported a substantial net loss in Q1 2026, primarily due to $442 million in charges from divesting and idling Brazilian facilities, alongside increased raw material costs leading to production curtailments.

check_boxKey Events

• Significant Q1 Net Loss

  The company reported a net loss of $257.6 million, or $0.81 per diluted share, a sharp reversal from a net income of $238.1 million, or $0.75 per diluted share, in the prior year period.

• Major Strategic Charges

  The Q1 loss was significantly impacted by approximately $442 million in pre-tax charges related to the divestiture of the Araxá mining and chemical complex and idling of the Patrocínio complex in Brazil. This includes a $233 million impairment loss on assets held for sale and $159 million in other operating expenses.

• Production Curtailments Announced

  Due to elevated raw material prices, Mosaic is taking initial steps to partially curtail phosphate production at its Louisiana and Bartow, Florida locations and scaling back production in Brazil.

• Antitrust Lawsuits

  The company is facing multiple putative antitrust class action lawsuits, filed in March 2026, alleging anticompetitive conduct in the U.S. fertilizer market. A hearing with the U.S. Judicial Panel on Multidistrict Litigation (JPML) is scheduled for May 28, 2026.

auto_awesomeAnalysis

This quarterly report details a significant financial downturn for Mosaic, with a substantial net loss driven by strategic asset impairments and high raw material costs. The $442 million in charges related to divesting the Araxá complex and idling Patrocínio facilities highlight a major portfolio optimization effort, but also reflect significant one-time costs. The decision to curtail phosphate production in the U.S. and Brazil signals ongoing operational challenges due to persistent high input costs, which severely impacted gross margins. These negative financial and operational developments, coupled with ongoing antitrust litigation, present a challenging outlook for the company, especially as its stock trades near 52-week lows.